Pneumococcal vaccines around the world
Conjugate vaccines targeting Streptococcus pneumoniae were introduced into the Australian National Immunisation Program for infants in 2005.
Conjugate vaccines targeting Streptococcus pneumoniae were introduced into the Australian National Immunisation Program for infants in 2005.
This talk will provide background of where tuberculosis fits into the context of the child survival agenda as well as the global tuberculosis control challenges. It will review the main challenges, both the need to do much better with what we have and the need for new and innovative tools particularly in diagnostics.
Nigel will be launching the Melbourne Vaccine Education Centre (MVEC), which is modeled on the Children’s Hospital of Philadelphia ‘Vaccine Education Centre’. MVEC will be based at the Melbourne Children’s campus, linking the campus partners and Monash Children’s Hospital.
Latest information on epidemiology, pathogenesis, transmission and treatment of the Bairnsdale/Buruli ulcer (BU). BU has been made legally notifiable in Victoria from January 2004 due to the high number of Australian cases occurring in Victoria, one third of which are children.
Using the available scientific evidence to help clinicians optimise protection from vaccine preventable diseases in children and adolescents with underlying special risk conditions.
Overview of the current state of diagnostics for TB including the use of novel immune-based methods to diagnose latent TB infection and active TB disease in children. Better methods to diagnosis TB have been identified as a key priority by the WHO.